Open access
Open access
Powered by Google Translator Translator

RCT | Superior progression-free survival with Venetoclax-based regimens in first-line CLL treatment

22 May, 2023 | 13:32h | UTC

First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary: First-Line Venetoclax Combinations vs Chemoimmunotherapy in Fit Patients With CLL – The ASCO Post


Commentary on Twitter


Stay Updated in Your Specialty

Telegram Channels

WhatsApp alerts 10-day free trial

No spam, just news.